(6R,7R)-7-((E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((1-methylpyrrolidin-1-ium-1-yl)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,97164-57-3-Amadis Chemical-Amadis Chemical

홈 > 제품 카탈로그 > 분자 빌딩 블록 > (6R,7R)-7-((E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((1-methylpyrrolidin-1-ium-1-yl)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

[CAS No.97164-57-3] A1291063 (6R,7R)-7-((E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((1-methylpyrrolidin-1-ium-1-yl)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate 97%

편집 후 검색

카탈로그 번호: A1291063

Cas No.: 97164-57-3

분자식: C₁₉H₂₄N₆O₅S₂

분자량: 480.56

MDL No: MFCD23115883

EINECS:

주문/견적 문의/기술 지원

전화: 0086-571-89925085
주문하기 & 문의: sales@amadischem.com
기술 지원: tech@amadischem.com

일괄 문의

*당사(本公司)의 모든 화학물질은 실험실 및 제조 용도로만 사용하십시오.

품질 관리 [97164-57-3]

NMR

CNMR

HPLC

LC-MS

관련 문서 [97164-57-3]

SDS

Specification

MOL

SDF

기본 정보 [97164-57-3]

Pubchem ID:

보관 요건: Store in 2-8°C for long term (months)

동의어: (6R,7R)-7-((E)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((1-methylpyrrolidin-1-ium-1-yl)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

Smiles: [O-]C(C1=C(C[N+]2(C)CCCC2)CS[C@@]3([H])N1C([C@@]3([H])NC(/C(C4=CSC(N)=N4)=N/OC)=O)=O)=O

Inchi: InChI=1S/C19H24N6O5S2/c1-25(5-3-4-6-25)7-10-8-31-17-13(16(27)24(17)14(10)18(28)29)22-15(26)12(23-30-2)11-9-32-19(20)21-11/h9,13,17H,3-8H2,1-2H3,(H3-,20,21,22,26,28,29)/b23-12+/t13-,17-/m1/s1

InchiKey: HVFLCNVBZFFHBT-FKULVZFESA-N

외관:

녹는점:

끓는점:

인화점:

안전 정보 [97164-57-3]

픽토그램:

신호어: Warning

UN No.:

위험 등급:

포장 등급:

위험성 표시: H302;H315;H319;H335

예방 조치 문구: P261;P305+P351+P338

관련 문헌 [97164-57-3]

죄송합니다, 관련 문헌이 없습니다

유사 제품 [97164-57-3]

A1292808 112258-91-0

Cefepime sulfoxides

Reason:분자 빌딩 블록

A1292584 133162-90-0

Cefepime Impurity 20

Reason:분자 빌딩 블록

A1260224 178601-88-2

Cefdinir CP Impurity R

Reason:분자 빌딩 블록

A1258716 66340-28-1

Cefotaxime EP Impurity B

Reason:분자 빌딩 블록

A1258667 71091-93-5

Cefdinir Impurity 1

Reason:분자 빌딩 블록

A839659 79350-37-1

Cefixime

Reason:분자 빌딩 블록

A842445 88040-23-7

Cefepime

Reason:분자 빌딩 블록

A1204536 64485-93-4

Cefotaxime sodium

Reason:분자 빌딩 블록

A1260728 127770-93-8

Cefdinir Impurity S

Reason:분자 빌딩 블록

A970538 2477791-28-7

Cefpodoxime-d3

Reason:분자 빌딩 블록

제품 상세 정보 [97164-57-3]

죄송합니다, 제품 상세 정보가 없습니다

열람 기록

A1254285 35984-92-0

β-D-Allofuranuronic acid, 5-[(aminoacetyl)amino]-1,5-dideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)- (9CI)

A1249176 1008-73-7 97%

4-Phenyloxolan-2-one

A20326 610-30-0 97%

2,4-Dinitrobenzoic acid

A801316 105776-13-4 97%

1H-Indole-2-carboxylicacid, 4,6-dimethoxy-, methyl ester

A808169 14406-17-8 97%

(2S)-2-(tert-butoxycarbonylamino)-5-methoxy-5-oxo-pentanoic acid;N-cyclohexylcyclohexanamine

A866997 68697-61-0 97%

DL-Tyrosine methyl ester hydrochloride

A870465 54398-65-1 97%

cyclopropyl-(4-methoxyphenyl)methanamine

A874819 349405-34-1 97%

3-Bromo-N-cyclopentylbenzamide

A876163 30510-67-9 97%

2-Amino-N-cyclopropylbenzamide

A1103478 1142198-09-1 97%

Methyl 3,4,5-triethoxy-2-nitrobenzoate

A1106771 110514-23-3 97%

3-(3,5-Dimethylpiperidin-1-yl)propan-1-ol

A1165043 53749-38-5

(10-Carbomethoxydecyl)dimethylchlorosilane

A1092935 884048-32-2 97%

(6-fluoro-1H-indol-2-yl)methanol

A901760 1158749-82-6 97%

6-methyl-1,6-diazaspiro[3.4]octane

A903541 1318734-99-4 97%

(R)-3-(4-Bromophenoxy)-2-methylpropane-1,2-diol

A908348 1270063-87-0 97%

(S)-3-Cyclobutylmorpholine

A925676 1018307-27-1

2-1-(Methylsulfonyl)-2-piperidinylethanamine

A928974 1807542-82-0 97%

3-Fluoroquinolin-7-amine

A970854 2417988-00-0 97%

A1013541 318248-80-5 97%

2-PHENYL-5-[1-(PHENYLSULFONYL)-1H-PYRAZOL-3-YL]-1,3-THIAZOLE

경쟁력 있는 가격

효율적인 물류

기술 지원

충분한 재고

화학물질 키워드 알파벳 순

CAS 첫 번째 숫자:

1 2 3 4 5 6 7 8 9

CAS 길이:

5 6 7 8 9 10

화학명 첫 글자:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

입문

결제 및 배송

반품 및 환불

회사 소개

참고 문서

RS 위험 문구

GHS 유해성 정보

서비스

화학물질 카탈로그

분석 서비스

0086-571-89925085

sales@amadischem.com

중국 저장성 항저우시 위항구 홍량항 1번, 우편번호: 311100

© Copyright 2024 Amadis Chemical Company Limited. 판권 소유.